Get the Stockscreener App
1.65
3.12%
0.05
Sana Biotechnology Inc Stock (SANA) Forecast
The Sana Biotechnology Inc (SANA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.5095, representing a +112.70% increase from the current price of $1.65. The highest analyst price target is $4.2806, and the lowest is $2.7384.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SANA Price Target
Average 9.7538
(+491.14% Upside)
Is Sana Biotechnology Inc (SANA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 30.33 | Neutral |
| STOCH(9,6) | 8.342 | Buy |
| STOCHRSI(14) | 10.54 | Buy |
| MACD(12,26) | -0.3494 | Sell |
| ADX(14) | 22.14 | Neutral |
| William %R | -92.48 | Buy |
| CCI(14) | -112.23 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.0205
Sell
|
1.9435
Sell
|
| MA20 |
2.285
Sell
|
2.2124
Sell
|
| MA50 |
2.9543
Sell
|
2.8715
Sell
|
| MA100 |
3.8849
Sell
|
3.7562
Sell
|
| MA200 |
5.7928
Sell
|
4.51
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SANA could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on SANA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 30.33 indicates that SANA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 8.342 indicates that SANA is oversold. This indicates that SANA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.54 indicates that SANA is oversold. This suggests that SANA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.14 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -112.23 indicates that SANA is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term SANA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sana Biotechnology Inc financial reports and earnings history, Sana Biotechnology Inc (SANA) stock could reach $30.33 by 2030, $104.55 by 2040 and $45.76 by 2050. See the projected annual prices until 2050 of the Sana Biotechnology Inc stock below:
- Sana Biotechnology Inc (SANA) is expected to reach an average price of $21.91 in 2035, with a high prediction of $22.41 and a low estimate of $22.22. This indicates an $1,228% rise from the last recorded price of $1.65.
- Sana Biotechnology Inc (SANA) stock is projected to chart a bullish course in 2040, with an average price target of $107.42, representing an $6,410% surge from its current level. The forecast ranges from a conservative $105.84 to a sky-high $104.55.
- Our analysts predict Sana Biotechnology Inc (SANA) to jump 5,418% by 2045, soaring from $91.08 to an average price of $91.04, potentially reaching $92.00. While $91.08 is the low estimate, the potential upside is significant.
- Sana Biotechnology Inc (SANA) stock is expected to climb by 2050, reaching an average of $43.80, a $2,555% jump from its current level. However, a wide range of estimates exists, with high and low targets of $45.76 and $44.13, respectively, highlighting the market's uncertainty.
Sana Biotechnology Inc Stock (SANA) Year by Year Forecast
Sana Biotechnology Inc Stock (SANA) Price Forecast for 2025
Sana Biotechnology Inc Stock (SANA) is expected to reach an average price of $9.7538 in 2025, with a high prediction of $16.77 and a low estimate of $2.7384. This indicates an +491.14% rise from the last recorded price of $1.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.0606 | $2.7384 | $4.2806 | +267.31% |
| February, 2025 | $2.4828 | $4.4928 | $4.3217 | +50.47% |
| March, 2025 | $5.7349 | $4.3638 | $5.4749 | +247.57% |
| April, 2025 | $8.6676 | $7.9955 | $7.7876 | +425.31% |
| May, 2025 | $15.61 | $11.47 | $14.62 | +846.05% |
| June, 2025 | $17.05 | $15.49 | $15.96 | +933.45% |
| July, 2025 | $15.23 | $16.64 | $16.77 | +823.31% |
| August, 2025 | $13.47 | $13.78 | $14.20 | +716.17% |
| September, 2025 | $15.26 | $13.67 | $13.67 | +824.79% |
| October, 2025 | $15.45 | $16.16 | $16.19 | +836.47% |
| November, 2025 | $14.13 | $14.57 | $15.61 | +756.60% |
| December, 2025 | $13.29 | $12.66 | $13.81 | +705.25% |
Sana Biotechnology Inc Stock (SANA) Price Forecast for 2026
The predicted value for Sana Biotechnology Inc (SANA) in 2026 is set at an average of $10.45. Estimates vary from a peak of $13.27 to a trough of $7.6298, indicating an +533.31% surge from the present price of $1.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.65 | $12.00 | $11.41 | +666.59% |
| February, 2026 | $12.49 | $12.66 | $12.33 | +657.03% |
| March, 2026 | $13.46 | $13.24 | $12.70 | +715.95% |
| April, 2026 | $11.92 | $12.62 | $12.77 | +622.17% |
| May, 2026 | $12.93 | $13.15 | $12.64 | +683.51% |
| June, 2026 | $13.03 | $13.24 | $13.27 | +689.71% |
| July, 2026 | $11.82 | $11.88 | $12.74 | +616.54% |
| August, 2026 | $12.15 | $11.82 | $11.58 | +636.06% |
| September, 2026 | $12.08 | $12.16 | $11.96 | +631.98% |
| October, 2026 | $9.5899 | $9.7499 | $11.79 | +481.21% |
| November, 2026 | $7.2321 | $7.9521 | $9.2704 | +338.31% |
| December, 2026 | $7.5648 | $7.6298 | $7.7731 | +358.47% |
Sana Biotechnology Inc Stock (SANA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sana Biotechnology Inc (SANA) is $4.0579, with a high forecast of $8.0861 and a low forecast of $0.0297. This indicates an +145.93% increase from the last price of $1.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.4969 | $7.5669 | $7.3453 | +354.36% |
| February, 2027 | $7.4191 | $7.1786 | $7.0091 | +349.64% |
| March, 2027 | $6.8618 | $6.9318 | $6.9202 | +315.87% |
| April, 2027 | $7.854 | $6.6823 | $7.574 | +376.00% |
| May, 2027 | $8.4461 | $8.2245 | $8.0861 | +411.89% |
| June, 2027 | $6.2688 | $6.6488 | $8.0467 | +279.93% |
| July, 2027 | $6.161 | $6.5444 | $6.2899 | +273.39% |
| August, 2027 | $3.3682 | $5.1432 | $5.6322 | +104.13% |
| September, 2027 | $2.6259 | $3.5559 | $3.4993 | +59.14% |
| October, 2027 | $2.6519 | $0.5365 | $3.3819 | +60.72% |
| November, 2027 | $1.8598 | $0.0297 | $2.9814 | +12.71% |
| December, 2027 | $1.4571 | $0.1624 | $2.1592 | -11.69% |
Sana Biotechnology Inc Stock (SANA) Price Forecast for 2028
In 2028, Sana Biotechnology Inc (SANA) is projected to reach an average price of $19.12, with a high projection of $36.88 and a low estimate of $1.3715. This indicates an +1,059% rise from the last price of $1.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $29.26 | $1.3715 | $21.26 | +1,673% |
| February, 2028 | $27.89 | $29.60 | $28.11 | +1,590% |
| March, 2028 | $33.18 | $26.77 | $31.58 | +1,911% |
| April, 2028 | $36.64 | $36.28 | $36.88 | +2,120% |
| May, 2028 | $36.56 | $34.64 | $34.80 | +2,116% |
| June, 2028 | $36.04 | $36.91 | $35.61 | +2,084% |
| July, 2028 | $33.42 | $35.09 | $35.34 | +1,925% |
| August, 2028 | $27.83 | $29.30 | $30.64 | +1,586% |
| September, 2028 | $30.36 | $28.92 | $29.39 | +1,740% |
| October, 2028 | $29.94 | $30.97 | $29.98 | +1,715% |
| November, 2028 | $30.48 | $29.35 | $30.22 | +1,747% |
| December, 2028 | $32.15 | $32.62 | $31.74 | +1,849% |
Sana Biotechnology Inc Stock (SANA) Price Forecast for 2029
The 2029 price forecast for Sana Biotechnology Inc Stock (SANA) is $35.22 on average, with a high prediction of $39.64 and a low estimate of $30.80. This represents an +2,034% increase from the previous price of $1.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $39.28 | $33.40 | $38.29 | +2,281% |
| February, 2029 | $40.24 | $39.04 | $39.15 | +2,339% |
| March, 2029 | $39.75 | $39.60 | $39.64 | +2,309% |
| April, 2029 | $35.79 | $36.57 | $37.72 | +2,069% |
| May, 2029 | $36.90 | $35.66 | $35.43 | +2,136% |
| June, 2029 | $37.19 | $37.43 | $37.47 | +2,154% |
| July, 2029 | $34.36 | $36.17 | $36.42 | +1,982% |
| August, 2029 | $32.71 | $32.74 | $34.26 | +1,883% |
| September, 2029 | $32.50 | $31.73 | $32.00 | +1,869% |
| October, 2029 | $31.50 | $31.67 | $31.70 | +1,809% |
| November, 2029 | $32.00 | $31.95 | $31.24 | +1,839% |
| December, 2029 | $30.96 | $30.80 | $31.18 | +1,776% |
Sana Biotechnology Inc Stock (SANA) Price Forecast for 2030
Sana Biotechnology Inc Stock (SANA) is expected to reach an average price of $24.57 in 2030, with a high forecast of $30.37 and a low forecast of $18.76. This signifies an +1,389% surge from the last price of $1.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $30.39 | $30.72 | $30.33 | +1,742% |
| February, 2030 | $30.01 | $30.58 | $30.37 | +1,719% |
| March, 2030 | $28.19 | $28.56 | $29.60 | +1,609% |
| April, 2030 | $27.67 | $27.95 | $27.88 | +1,577% |
| May, 2030 | $27.35 | $27.77 | $27.74 | +1,558% |
| June, 2030 | $24.71 | $26.73 | $27.02 | +1,397% |
| July, 2030 | $21.58 | $22.30 | $23.98 | +1,208% |
| August, 2030 | $21.53 | $21.67 | $21.89 | +1,205% |
| September, 2030 | $20.80 | $21.07 | $20.98 | +1,161% |
| October, 2030 | $20.22 | $20.10 | $20.24 | +1,125% |
| November, 2030 | $19.29 | $19.38 | $19.59 | +1,069% |
| December, 2030 | $19.86 | $18.76 | $19.13 | +1,103% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):